Pigmentary Glaucoma

• CLINICAL_TRIALS trial_result · 2025-01-15
  Clinical Trial Update: Safety and Effectiveness of the Hydrus Microstent [NA]

  A clinical trial update indicates safety and effectiveness data for the Hydrus Microstent in open-angle glaucomas, but the study has been te…

• CLINICAL_TRIALS trial_result · 2024-06-21
  Clinical Trial Update: Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery [NA]

  A completed clinical trial compared the Hydrus Microstent to the iStent for lowering intraocular pressure in glaucoma patients undergoing ca…

• CLINICAL_TRIALS trial_result · 2020-08-27
  Clinical Trial Update: Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [Phase 2]

  Phase 2 dose-finding trial comparing latanoprost to a novel glaucoma treatment, with completed status and results posted.

• CLINICAL_TRIALS trial_result · 2019-12-10
  Clinical Trial Update: Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes [NA]

  A completed clinical trial comparing the Hydrus Microstent to two iStents for lowering intraocular pressure in phakic eyes with glaucoma has…

• CLINICAL_TRIALS trial_result · 2015-11-17
  Clinical Trial Update: IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty [NA]

  The document reports a completed clinical trial assessing intraocular pressure fluctuations in patients with primary open-angle glaucoma bef…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-01-24
  Clinical Trial Update: Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients

  This clinical trial update reports on the termination of a study evaluating continuous intraocular pressure monitoring in patients with pigm…

• CLINICAL_TRIALS trial_result · 2008-11-19
  Clinical Trial Update: Assessing Cosopt Switch Patients [Phase 4]

  Phase 4 clinical trial completed evaluating outcomes for patients switched to Cosopt (dorzolamide-timolol) in ocular hypertension and severa…